To further investigate the HSPA6 expressions and its clinical significance in breast cancer patients, we thus utilized the data from CPTAC, and results showed that the HSPA6 protein expressions were decreased in breast cancer tissues compared with normal tissues (Figure 6A). Here, HSPA6 is linked to breast carcinoma.